Navigation Links
PTC Therapeutics Receives Grand Challenges Explorations Funding
Date:11/7/2011

SOUTH PLAINFIELD, N.J., Nov. 7, 2011 /PRNewswire/ -- PTC Therapeutics, Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health and development challenges.  Dr. Zhengxian Gu, Director, Antiviral Biology will pursue an innovative global health research project, titled "Exploration of a Novel Mechanism Regulating HIV Latency."

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

Grand Challenges Explorations funds scientists and researchers worldwide to explore ideas that can break the mold in how we solve persistent global health and development challenges.  Dr. Zhengxian Gu's project is one of 110 Grand Challenges Explorations grants announced today.  

"We believe in the power of innovation—that a single bold idea can pioneer solutions to our greatest health and development challenges," said Chris Wilson, Director of Global Health Discovery for the Bill & Melinda Gates Foundation. "Grand Challenges Explorations seeks to identify and fund these new ideas wherever they come from, allowing scientists, innovators and entrepreneurs to pursue the kinds of creative ideas and novel approaches that could help to accelerate the end of polio, cure HIV infection or improve sanitation."  

Projects that are receiving funding show promise in tackling priority global health issues where solutions do not yet exist.  This includes finding effective methods to eliminate or control infectious diseases such as polio and HIV as well as discovering new sanitation technologies.

To learn more about Grand Challenges Explorations, visit www.grandchallenges.org.

Although HIV therapies are effective in dramatically reducing virus levels in infected patients, a small perce
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
2. Pharmacodynamic Data from Syndax Pharmaceuticals ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011
3. Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection
4. Echo Therapeutics Announces Warrant Exercise by Its Largest Shareholder
5. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Pearl Therapeutics Presents New Scientific Evidence Supporting Versatility of Its Novel Cosuspension MDI Platform
7. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
8. Pneumonia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
9. Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018
10. Osteoarthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11. Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)("the Company" or "RegeneRx") today ... from the Israeli patent office with claims for administering ... damage caused by an increase in blood flow, as ... after a blockage causing a heart attack or in ... can be caused to the heart attack or stroke ...
(Date:3/26/2015)... March 26, 2015  Flexpoint Sensor Systems, Inc. (OTCBB: ... it has received and shipped during the last 90 ... of interest in the sensors for gloves and medical ... have had custom sensors built for them. Some of ... custom sensors for medical rehab; a major international electronics ...
(Date:3/26/2015)... VEGAS , March 26, 2015 ... sales agreement with Radlink, Inc., an emerging global ... real-time image guidance with its hip replacement systems. ... commitment to help improve patient outcomes, increase patient ... conjunction with the 81st annual meeting of the ...
Breaking Medicine Technology:RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Flexpoint Sensor Systems, Inc. Expands Customer Base with New Orders of Sensors 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 2DePuy Synthes Companies Announces Exclusive Agreement With Radlink To Help Address Key Challenges In Hip Replacement 3
... Mylan Inc. (Nasdaq: MYL ) today ... entered into a settlement agreement with Warner Chilcott resolving ... as Norethindrone and Ethinyl Estradiol Tablets USP (Chewable), 0.4 ... mg (28-Day Regimen). This medication is an oral contraceptive. ...
... NEW YORK, Oct. 19, 2011 Reportlinker.com announces ... in its catalogue: Syncria ... 2020 http://www.reportlinker.com/p0657174/Syncria-Type-2-Diabetes-–-Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... and Forecasts to 2020 Summary ...
Cached Medicine Technology:Mylan Announces Femcon® Fe Settlement Agreement 2Syncria (Type 2 Diabetes) - Analysis and Forecasts to 2020 2Syncria (Type 2 Diabetes) - Analysis and Forecasts to 2020 3Syncria (Type 2 Diabetes) - Analysis and Forecasts to 2020 4Syncria (Type 2 Diabetes) - Analysis and Forecasts to 2020 5
(Date:3/26/2015)... March 26, 2015 Let’s not lose ... Fresh produce are today’s traffic magnets. Three out of ... because of their produce department, according to a Packaged ... as people are looking to add more fruits and ... Produce Manager® Day is April 2. As featured in ...
(Date:3/26/2015)... Alliance Healthcare Foundation (AHF), a nonprofit ... the poor and underserved in San Diego and Imperial ... $1 million award, the Innovation Initiative (i2). , ... round of our Innovation Initiative Award,” AHF Executive Director ... creative and ambitious projects in the past with this ...
(Date:3/26/2015)... UC Davis will establish a prestigious, leading-edge center ... A Silvio O. Conte Center for Basic or Translational ... the United States. , The center will be funded ... of Mental Health, which will allow UC Davis’ Conte ... of schizophrenia may be dysregulation of immune molecules that ...
(Date:3/26/2015)... March 26, 2015 Florida Hospital teamed up ... For Your Health campaign and live Dr. Oz event, which ... March 21st. More than a thousand people came out to ... living. , The world renowned cardiothoracic surgeon and Emmy ... Linda Hurtado and a panel of experts for the live ...
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
Breaking Medicine News(10 mins):Health News:Applications Open for $1M Innovation Initiative Award from Alliance Healthcare Foundation 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 2Health News:Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians 3Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3
... , DENVER, July 14 Clinic Service Corporation (CSC), ... has secured an agreement to be the exclusive provider of medical ... , "This is another key new contract for us," ... and deep roots in the Littleton community. Our goal is to ...
... , , , , ... Hoyer, Chairman Henry Waxman, Chairman Charles Rangel, Chairman George Miller, Chairman John ... Capitol this afternoon to discuss legislation introduced today by the Tri-Committees on ... Below are the Speaker,s opening remarks and closing statement. A transcript ...
... , FLEMINGTON, N.J., July 14 A new national ... that the H1N1 Swine Flu poses some level of risk for a ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO ... conducted last night by HCD Research using its MediaCurves.com(R) website, and the ...
... , BEDFORD, N.H., July 14 Emerson Ecologics, ... Manager and Dr. Christine Toomasi has been named Professional Services Specialist. ... practitioner customers. , , Dr. ... Services team. Her enthusiasm, industry knowledge and experience in the ...
... , PHOENIX, July 14 Just weeks after the ... The World Egg Bank (TWEB) today announced a new loan program ... , Offered through Kansas-based Home National Bank, the program can ... or the total cost of an in vitro fertilization (IVF) procedure using fresh ...
... , WASHINGTON ., ... of the Congressional Urban Caucus, release d this statement ... the American Affordable Health Choices Act: , ... is the day that health care reform for all Americans begins its ...
Cached Medicine News:Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 2Health News:Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 3Health News:Physicians' Level of Concern for H1N1 Swine Flu Pandemic Highest Since April 2Health News:Physicians' Level of Concern for H1N1 Swine Flu Pandemic Highest Since April 3Health News:Emerson Ecologics Expands Their Team of Naturopathic Doctors 2Health News:New Fertility Financing for Donated Eggs Fills Void Left by Capital One 2Health News:Urban Caucus Chair Says Healthcare Reform Means You Can Have Your Care and Keep It Too 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Sodium in serum and plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
Medicine Products: